Sales of cardiovascular products rose 15.9% in the quarter, helping Boston Scientific beat estimates.
Boston Scientific’s stock heads for record high as earnings shine and company offers upbeat guidance
Read Next
- Why Choose Solana for Your Next DeFi Application: A Comprehensive Guide
- SFC issues notices to Interactive Brokers, SBI, Monmonkey, Soochow to freeze certain client accounts
- Private consumption driving growth in Q3 with rural India taking lead: RBI, ET BFSI
- Nvidia (NVDA) stock slumps despite Q3 earnings beat
- India’s consumer durable makers to log 11-12 pc growth in FY25, ET BFSI
- Binance Offers NOTCOIN Red Packet Giveaway via Binance Pay
- Snowflake (SNOW) Q3 earnings report 2025
